---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-001663"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:08:14.301159+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Dare Bioscience furnishes corporate presentation for investor meetings; no specific material news disclosed.

## Summary
- Filing under Item 7.01 discloses a corporate presentation dated January 8, 2024, used in investor meetings.
- Presentation content is not provided in the filing; no new financial or operational data released.
- No guidance, product milestones, or material events are reported beyond the presentation availability.

## SEC filing metadata
- accession: 0001493152-24-001663
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315224001663/0001493152-24-001663-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315224001663/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-001663
- JSON: https://secwatch.observer/filing/0001493152-24-001663.json
- Plain text: https://secwatch.observer/filing/0001493152-24-001663.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.